These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 17654443)

  • 1. The impact of insulin resistance on endothelial function, progenitor cells and repair.
    Cubbon RM; Rajwani A; Wheatcroft SB
    Diab Vasc Dis Res; 2007 Jun; 4(2):103-11. PubMed ID: 17654443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of insulin resistance on endothelial progenitor cells and vascular repair.
    Cubbon RM; Kahn MB; Wheatcroft SB
    Clin Sci (Lond); 2009 Aug; 117(5):173-90. PubMed ID: 19630751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does drug therapy reverse endothelial progenitor cell dysfunction in diabetes?
    Desouza CV
    J Diabetes Complications; 2013; 27(5):519-25. PubMed ID: 23809765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating endothelial progenitor cells characterization, function and relationship with cardiovascular risk factors.
    Balbarini A; Barsotti MC; Di Stefano R; Leone A; Santoni T
    Curr Pharm Des; 2007; 13(16):1699-713. PubMed ID: 17584100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological approaches to improve endothelial repair mechanisms.
    Besler C; Doerries C; Giannotti G; Lüscher TF; Landmesser U
    Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1071-82. PubMed ID: 18793110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Endothelial progenitor cells and atherosclerosis].
    Hamed S; Roguin A
    Harefuah; 2006 May; 145(5):358-61, 397. PubMed ID: 16805218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial progenitor cells in cardiovascular disorders.
    Shantsila E; Watson T; Lip GY
    J Am Coll Cardiol; 2007 Feb; 49(7):741-52. PubMed ID: 17306702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial progenitor cells: a promising therapeutic alternative for cardiovascular disease.
    Dong C; Goldschmidt-Clermont PJ
    J Interv Cardiol; 2007 Apr; 20(2):93-9. PubMed ID: 17391216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular repair by endothelial progenitor cells.
    Zampetaki A; Kirton JP; Xu Q
    Cardiovasc Res; 2008 Jun; 78(3):413-21. PubMed ID: 18349136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulating putative endothelial progenitor cells for the treatment of endothelial dysfunction and cardiovascular complications in diabetes.
    Wils J; Favre J; Bellien J
    Pharmacol Ther; 2017 Feb; 170():98-115. PubMed ID: 27773788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Circulating endothelial cells, microparticles and progenitors: towards the definition of vascular competence].
    Sabatier F; Lacroix R; Camoin-Jau L; Anfosso F; Sampol J; Dignat-George F
    Rev Med Interne; 2011 Jan; 32(1):54-63. PubMed ID: 20541851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How to improve endothelial repair mechanisms: the lifestyle approach.
    Möbius-Winkler S; Linke A; Adams V; Schuler G; Erbs S
    Expert Rev Cardiovasc Ther; 2010 Apr; 8(4):573-80. PubMed ID: 20397830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of endothelial progenitor cells: a new putative effect of several cardiovascular drugs.
    António N; Fernandes R; Rodriguez-Losada N; Jiménez-Navarro MF; Paiva A; de Teresa Galván E; Gonçalves L; Ribeiro CF; Providência LA
    Eur J Clin Pharmacol; 2010 Mar; 66(3):219-30. PubMed ID: 20012029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial progenitor cells in the natural history of atherosclerosis.
    Fadini GP; Agostini C; Sartore S; Avogaro A
    Atherosclerosis; 2007 Sep; 194(1):46-54. PubMed ID: 17493626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stem cells in kidney diseases.
    Soler MJ; José Tomas OP
    J Stem Cells; 2012; 7(4):245-59. PubMed ID: 24196799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy?
    Werner N; Nickenig G
    Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):257-66. PubMed ID: 16322535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pioglitazone increases the numbers and improves the functional capacity of endothelial progenitor cells in patients with diabetes mellitus.
    Wang CH; Ting MK; Verma S; Kuo LT; Yang NI; Hsieh IC; Wang SY; Hung A; Cherng WJ
    Am Heart J; 2006 Dec; 152(6):1051.e1-8. PubMed ID: 17161050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial dysfunction and cardiovascular disease--the lull before the storm.
    Marx N; Grant PJ
    Diab Vasc Dis Res; 2007 Jun; 4(2):82-3. PubMed ID: 17654440
    [No Abstract]   [Full Text] [Related]  

  • 19. Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease.
    Sen S; McDonald SP; Coates PT; Bonder CS
    Clin Sci (Lond); 2011 Apr; 120(7):263-83. PubMed ID: 21143202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of reendothelialization after arterial injury.
    Versari D; Lerman LO; Lerman A
    Curr Pharm Des; 2007; 13(17):1811-24. PubMed ID: 17584110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.